Loading data for IXHL — first visit, this takes a few seconds.
Incannex Healthcare Inc. (IXHL)
NasdaqCM: IXHL
· 실시간 가격 · USD
3.44
+0.08 (2.38%)
종가 기준: Aug 19, 2026, 8:00 PM
3.40
-1.16%
애프터마켓: 7:54 PM
Incannex Healthcare Inc. (IXHL) Stock Price, Analysis & Data
2.38% (1D)
데이터 없음
IXHL 소개
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical deve...
전체 기업 정보재무 실적
2024년 Incannex Healthcare의 매출은 12K로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -18.46M로, -62.18% 감소했습니다.
재무제표
